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and Wales from 1993 to 2000, an
estimated 2–10 secondary cases
would have been prevented if attack
rates were 5% and each patient had 4
contacts. The number of index cases
needed to be detected to prevent 1
death (assuming 6%–10% case-fatali-
ty ratio) would have been 150–180
with attack rates of 5% and 50–83
with attack rates of 30%. Thus, deaths
were not likely to have been prevent-
ed during this period by screening.
Are the parameter estimates valid?
We focused on secondary cases, but
spread in outbreaks may be exponen-
tial, so the effect of missing cases may
be greater once tertiary cases and fur-
ther spread are taken into account.
Vaccination coverage may be higher
or lower in different risk groups.
Secondary attack rates in the literature
are reported from outbreaks and
regions with vulnerable populations
during periods of high incidence and
may not apply in affluent countries
with high coverage and may be <5%.
Adult protection may be better than
indicated by serosurveys and may
have improved in the United
Kingdom with use since 1994 of com-
bined tetanus-diphtheria toxoid vac-
cine instead of tetanus toxoid for
injuries (5). 
Outbreaks are not reported from
countries without routine screening
(1), which indicates that some of our
assumptions and estimates may be
incorrect. Alternatively, this fact may
indicate defective surveillance; coun-
tries that do not detect primary cases
may not detect secondary cases. 
Surveillance for diphtheria in
European Union member states varies
widely (1). Only 5 of 19 reporting
countries screen throat swabs routine-
ly for corynebacteria, raising doubts
about the quality of surveillance. The
absence of reports of diphtheria may
not reflect the absence of disease or of
circulating toxigenic corynebacteria.
Our results show the possible conse-
quences of not detecting such infec-
tions and help demonstrate the public
health priority of diphtheria surveil-
lance.
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Rickettsia slovaca
Infection, France 
To the Editor: Rickettsia slovaca
was first isolated in 1968 in a
Dermacentor marginatus tick collect-
ed in Slovakia, and serologic evidence
of infection with this bacteria was
reported in patients with enlarged
lymph nodes and a scalp eschar after
being bitten by a tick (1). However,
the first proven case of R.  slovaca
infection was reported only in 1997 in
France (2). This rickettsiosis is called
tickborne lymphadenopathy (TIBO-
LA) because the most pronounced
sign is lymph node enlargement. In
Spain the same condition is called
Dermacentor-borne-necrosis-erythe-
ma lymphadenopathy (3,4).
In this study, we describe 14 new
patients with TIBOLA from southern
France who sought treatment from
January 2004 to May 2005 and com-
pare the features of these patients with
those in whom Mediterranean spotted
fever (MSF) was diagnosed during
the same period. All the patients were
referred to our center with a suspected
rickettsial infection characterized by a
tick bite located on the scalp, an inoc-
ulation eschar, and enlarged lymph
nodes (see online Appendix Figure,
available at http://www.cdc.gov/nci-
dod/EID/vol12no03/05-0911-appG
.htm). For each patient, an acute-
phase and a convalescent-phase
serum sample were obtained for sero-
logic analysis. Culture and poly-
merase chain reaction (PCR) were
performed on tick, skin biopsy, or
blood specimens. A multiple-antigen
immunofluorescence assay (IFA) was
performed by using 5 spotted fever
group (SFG) rickettsial antigens: R.
conorii conorii, R. slovaca, R. helveti-
ca,  R.  sibirica mongolitimonae, and
R. felis. Titers of at least 64 for
immunoglobulin G (IgG) and 32 for
IgM in acute-phase serum samples,
evidence of seroconversion with 4-
fold increases in IgG titers, or both,
were considered as evidence of recent
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infections with a Rickettsia sp. (5).
For serum specimens confirmed by
IFA at the species level, Western
immunoblotting and cross-adsorption
assays procedures were performed as
described elsewhere (6) by using R.
conorii conorii and R. slovaca anti-
gens. Patients with a definite serolog-
ic diagnosis at the species level were
analyzed for their epidemiologic and
clinical information. 
Culture from skin biopsy specimen
and ticks were injected into human
embryonic lung cells and cultivated
into shell-vial culture as previously
described (7). DNA was extracted
from skin biopsy specimens, acute-
phase serum samples, and ticks by
using the QIAamp DNA Mini Kit
(Qiagen, Hilden, Germany) (8).
Standard PCR was performed with
primers suitable for hybridization
within the conserved region of genes
coding for outer membrane protein A
(ompA) and citrate synthase (gltA) (8). 
Among the 14 patients in a scalp
lesion and cervical or occipital (1
case) lymph node enlargement devel-
oped after they were bitten by a tick, 9
were female (1 was pregnant) and 5
were male. The median (range) age
was 34.9 (5–85) years with half of the
patients <10 years of age. The incuba-
tion period ranged from 5 to 15 days
(median 10.5 days; n = 7). Only 3
patients had fever. All patients fully
recovered with doxycycline or, for the
pregnant patient, josamycin therapy.
Serology confirmed the diagnosis of
R. slovaca infection for 10 patients by
microimmunofluorescence and
Western blot analysis after cross-
adsorption studies (online Appendix
Table, available from http://www.cdc.
gov/ncidod/EID/vol12no03/05-
0911.htm#apptable).  R. slovaca was
amplified by PCR for 7 cases, includ-
ing 3 skin biopsy specimens, 3
Dermacentor marginatus ticks, and 1
acute-phase serum sample (Appendix
Table). Three isolates (2 from skin
biopsy specimens and 1 from a tick)
were obtained by using the shell-vial
culture assay. During the period of our
study, in the same French region, 40
patients with MSF were clinically and
laboratory diagnosed using the same
procedures. The median (range) age
was 54.2 (5–85) years with only 3
children <10 years of age (compared
to 7/7 children with R. slovaca infec-
tion, p = 0.0015). MSF occurred
mainly during the summer, whereas
R. slovaca infection was seen during
the colder months with 6 cases from
October to January and 8 cases from
February to May (Figure). 
In France, R. conorii has long been
considered to be the only SFG rick-
ettsiosis but R. slovaca may also be
prevalent (9), contributing 25% of the
cases in the present study. This organ-
ism is also a common cause of disease
in Hungary and in La Rioja, Spain (3).
These data suggest that TIBOLA
mainly occurs in young children,
affects women predominately, and
occurs primarily during the colder
months (9,10). As previously reported
(9), we found that standard microim-
munofluorescence serologic testing
was insensitive and that Western blot
is more useful and allows identifica-
tion to the species level after cross-
adsorption studies. Finally, DNA
amplification by PCR from skin biop-
sy tissue, serum samples, or in ticks
allowed confirmation of the diagnosis
in only 50% of the cases, which sug-
gests that other rickettsial species may
be responsible for TIBOLA.
Epidemiologic and clinical presenta-
tions are so characteristic that the clin-
ical diagnosis should be considered in
patients who have been bitten on the
scalp during the colder months. In
Europe, R. slovaca infection is likely
to be a significant cause of cervical
lymph node enlargement, and micro-
biologic investigation and tick analy-
sis will underline the relative impor-
tance of this disease. 
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Cutaneous
Anthrax, Belgian
Traveler 
To the Editor: Anthrax is a rare
zoonotic disease among travelers. The
clinical spectrum includes cutaneous
lesions, respiratory anthrax, pharyn-
geal inflammation, gastrointestinal
infection, septicemia, and meningitis.
Interest in anthrax increased after the
bioterrorist attacks in the United
States in 2001. The following case
history describes a cutaneous infec-
tion suspected to be anthrax in a
tourist who had indirect contact with
dead mammals in a disease-endemic
area. 
After indirect contact with dead
antelopes and a hippopotamus in
Botswana, an acute necrotic lesion
developed on a finger of a 31-year-
old, healthy, female Belgian woman.
The lesion became covered with a
black crust, followed by massive
swelling of the hand and arm. The
clinical aspect and history strongly
suggested cutaneous anthrax. This
diagnosis was supported by serocon-
version to protective antigen of
Bacillus anthracis and the presence of
antibodies against lethal factor. The
bacterium itself could not be cultured
or identified by polymerase chain
reaction (PCR). Other members of the
group with which she traveled were
contacted, but no other cases were
reported. 
The Belgian woman traveled with
friends to Namibia, Botswana, and
South Africa from December 12,
2004, until January 22, 2005. She vis-
ited Chobe National Park in Botswana
early January 2005. On January 8, a
small, painless, vesicular lesion
developed on the dorsal side of her
fourth left finger. This lesion
increased in size quickly and devel-
oped a black aspect with a red elevat-
ed border. Small vesicles appeared in
the immediate vicinity of the primary
lesion. No pus was noted. Her general
condition was good. She treated her-
self with amoxicillin-clavulanic acid
2 gm/day for 3 days. The next day,
massive edema of the finger, hand,
and left arm developed. When admit-
ted to a hospital in Johannesburg, her
left arm and hand were massively
swollen with painful left axillary lym-
phadenopathy. Her temperature never
exceeded 37.8°C. Wound cultures
showed only the presence of viridans
streptococci, bacteria that are not
implicated in wound infections. The
patient was treated with intravenous
ciprofloxacin, gentamicin, tetracy-
cline, flucloxacillin, and topical
mupirocin. She was discharged after 6
days with oral flucloxacillin and
returned to Belgium on January 22.
On February 4, her general condition
was excellent; the edema had dimin-
ished. A painless necrotic lesion on
the left fourth finger measured 3 cm2
(Figure). She mentioned minor dis-
comfort of her left underarm and loss
of sensation at the distal radial side of
the left underarm. She could not
extend the terminal phalanx of the
fourth left finger because the underly-
ing tendon had been destroyed. The
left axillary lymph nodes were still
slightly swollen. No evidence indicat-
ed parapox viral infection or necrotic
arachnidism. Upon questioning, she
mentioned that in Chobe National
Park, some fellow travelers had
manipulated the legs of dead
antelopes. One person had climbed on
a dead hippo for a picture and sank
into the putrefying carcass. He soon
afterwards cleaned a small abrasion
on the patient’s finger. Some hours
later, all group members washed their
hands in a common small plastic
basin containing water and chlorox-
ylenol. 
Full blood count, erythrocyte sedi-
mentation rate, and biochemistry were
normal. Antistreptolysin O levels
were within normal limits. Serologic
test results for rickettsiae, orthopox-
viruses, and Bartonella henselae were
negative. The patient was not
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